Daiichi Sankyo poised to add another ADC blockbuster with datopotamab deruxtecan for non-squamous…
GlobalData estimates the drug to earn $3.12 billion by 2029
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
India pharma giants and global big pharma join forces for NMEs commercialisation in India:…
The focus is on introducing new molecular entities (NMEs) into India, with both parties contributing to accelerate…
Top 20 global biopharma companies report 1.6 per cent per cent market cap growth to $3.67 tn in…
Four companies – Lilly (59.2 per cent), Novo Nordisk (51.5 per cent), Vertex Pharmaceuticals (41.4 per cent) and Regeneron…
Alkaloid has developed ready-to-use liquid Omeprazole
This drug is primarily designed to treat reflux esophagitis and GERD in young children unable to swallow tablets, as well as in…
Alirocumab can address unmet needs in pediatric familial hypercholesterolemia: GlobalData
Praluent (alirocumab) is a monoclonal antibody against proprotein convertase subtilisin kexin type 9 (PCSK9), an enzyme that…
Iovance’s AMTAGVI (lifileucel) gets US FDA accelerated approval for advanced melanoma
AMTAGVI is the first FDA-approved T cell therapy for a solid tumor cancer and first treatment option for advanced melanoma after…
Colorectal cancer market across 8MM to reach $21.8 bn in 2031: GlobalData
This uptrend is primarily driven by rising diagnosis rates, notably in key markets like the US and China and approvals of 13…
AstraZeneca’s DKD pipeline highlights potential to differentiate in kidney disease space: GlobalData
Unmet needs in the kidney disease space include next-generation therapies with alternate mechanisms of action and enhanced…
Aparna Group forays into pharma gets USFDA clearance for pharma manufacturing unit
Aparna Pharmaceuticals announced that its manufacturing facility, Aparna Organics, located in Pydibhimavaram, Srikakulalam, Andhra…
Fredun Pharma gets orders from SEA Countries
Also expands product development in veterinary care, and advances orthopaedic applications
Deal value increased by 19.2 per cent in Jan 2024, compared to Jan 2023: GlobalData
VC investments increased by 11.2 per cent in Jan 2024, compared to Jan 2023
Zydus gets tentative USFDA approval for Dexamethasone Tablets USP, 1 mg
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye…
Biocon Biologics Partners with Sandoz Australia for Trastuzumab and Bevacizumab
The agreement is effective from January 1, 2024 and commercialisation commenced on February 1, 2024
Algorithmic Biologics secures Pre-Series A funding
Proceeds of the fundraise will be used to support the product pipeline, building the sales organisation and furthering their…
Zydus gets USFDA nod for Dexamethasone Tablets USP, 0.5 mg, 0.75 mg, 1.5 mg, 4 mg and 6 mg and…
Dexamethasone is used to treat a number of different conditions, such as inflammation (swelling), severe allergies, adrenal…
Catalent to help Novo Nordisk address production demands for Ozempic and Wegovy: GlobalData
The acquisition of Catalent by Novo Holdings expects to see three new manufacturing sites added to Novo Nordisk’s arsenal, to…
DHL Express India and Aragen LifeSciences sign GoGreen Plus partnership to reduce carbon emission
GoGreen Plus uses sustainable aviation fuel (SAF) to enable customers to reduce Scope 3 emissions
RxP expands life sciences real estate portfolio in Mumbai with $150+mn investment
RxP announces its expansion in Mumbai with the Navi Mumbai Research (NMR) District as part of its continued regional expansion…
US FDA gives record number of review designations to CRISPR drugs in 2023: GlobalData
Casgevy is the first CRISPR-based drug to receive marketing authorisation globally
SGD Pharma introduces new range of Type I tubular vials
It features Corning’s Velocity Vial coating technology